BKK PHARMACEUTICALS, LLC – Trademark Portfolio
Entity Type: 16
BKK PHARMACEUTICALS, LLC holds 48 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 47 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include XALIX, VYTONE, PLEXION, and WHEN ONE HEART BECOMES TWO. The owner is based in WILMINGTON, DE.
1000 N. WEST STREET, SUITE 1200, #943
WILMINGTON, DE 19801
Showing of trademarks Trademarks
Trademark Classifications
BKK PHARMACEUTICALS, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does BKK PHARMACEUTICALS, LLC have?
BKK PHARMACEUTICALS, LLC has 48 U.S. trademarks filed with the USPTO. Of these, 4 registered, 30 abandoned, 14 cancelled.
What trademark classes does BKK PHARMACEUTICALS, LLC file in?
BKK PHARMACEUTICALS, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are BKK PHARMACEUTICALS, LLC's most well-known trademarks?
BKK PHARMACEUTICALS, LLC's registered trademark portfolio includes well-known marks such as XALIX, VYTONE, PLEXION, and WHEN ONE HEART BECOMES TWO. These are among 4 currently registered trademarks in the portfolio.
What is BKK PHARMACEUTICALS, LLC's trademark registration success rate?
BKK PHARMACEUTICALS, LLC has a 8% trademark registration rate, with 4 out of 48 resolved applications resulting in successful registration. Currently, 0 applications are pending review.